Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: raymond marcotte who wrote (3308)	12/12/1997 12:34:00 AM
From: jack velte	Read Replies (4) \| Respond to of 23519

>>"A study of 123 impotent men treated with Vivus' Muse product at the Centre for Impotence and Fertility in Rome, Italy found that Muse failed to make 121 of the penises rigid. This test's endpoint was very different than Vivus' 1996 study, which used an ''Erection Assessment Scale.'' The Italian study actually measured the rigidity of each penis and concluded that the penises were not hard." << is there ONE person on this board that has tried the product that can honestly report their response to this product? we are all buying into a company that produces a product that we have never tested. -jack